Alendronate Sodium-Impurities | Pharmaffiliates

alendronate sodium and its Impurities

Alendronic acid was first described in 1978 and approved for medical use in the United States in 1995. It is available as a generic medication. Reference standards of Alendronate Sodium API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 4 results for alendronate sodium Impurities
PA 54 03000

Alendronate Sodium - API

Alendronate Sodium


  • Catalogue No.:PA 54 03000

  • CAS :

    129318-43-0

  • Molecular Formula : C4H12NNaO7P2

  • Molecular Weight : 271.08

PA USP1012780

Alendronate Sodium (1012780)

Alendronate Sodium (1012780)


  • Catalogue No.:PA USP1012780

  • CAS :

    121268-17-5

  • Molecular Formula : NA

  • Molecular Weight : NA

PA EPY0001727

Sodium alendronate trihydrate (Y0001727)

Sodium alendronate trihydrate (Y0001727)


  • Catalogue No.:PA EPY0001727

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

PA EPY0001678

Sodium alendronate for system suitability (Y0001678)

Sodium alendronate for system suitability (Y0001678)


  • Catalogue No.:PA EPY0001678

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA